Fosamax is leading to esophageal side effects

Merck is busy putting out fires about reports that their new bone-building drug, Fosamax is leading to esophageal side effects.

Fosamax (alendronate) CAN irritate the esophageal mucosa. It's no fact it's in the package labeling. But the severity of some cases seems to be worse than expected.

About 3 dozen patients have been hospitalized for severe esophageal irritation, erosions, and ulcerations.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote